# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T00:07:51.671912
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 19831 in / 5547 out
**Response SHA256:** d57a974ba6632667

---

Summary
This is an interesting and policy‑relevant paper that uses the ACA dependent‑coverage cutoff at age 26 to study how the “coverage cliff” affects the payer of childbirth. The dataset (2023 CDC Natality Public Use Files, N ≈ 1.64M births, mothers aged 22–30) is compelling, and the core finding—the age‑26 discontinuity raises Medicaid financing of births by about 2.7 percentage points while private insurance falls by about 3.1 points—is plausibly important for both health policy and public finance. The author(s) have thought about key empirical challenges: they use local linear RD implemented with rdrobust, report bias‑corrected CIs, run local randomization permutation tests, perform McCrary density and covariate balance tests, and show bandwidth sensitivity and heterogeneous effects by marital status and education.

That said, this manuscript is not yet ready for a top general interest journal. The empirical design faces several nontrivial measurement and identification issues that must be addressed more fully; some reporting and robustness details are missing or need strengthening; and some writing/organization choices should be improved to meet the bar for AER/QJE/JPE/ReStud/AEJ: Economic Policy. Below I provide a comprehensive, critical, and constructive review organized as you requested.

1. FORMAT CHECK (required, concrete)
- Length: The LaTeX source contains a long, fully-developed main text with an appendix. Based on the sections and content, the main text appears to be roughly 25–35 pages excluding references and appendix. My estimate: approximately 30 pages of main text (Sections 1–11) plus appendix material. The paper therefore likely meets the page minimum (25 pages) but you should report final compiled page count precisely in resubmission and ensure the main text (excluding references and online appendices) is ≥25 pages as required.
- References: The bibliography covers many relevant literatures (dependent coverage, RD methods, Medicaid/churning). However, several important methodological and applied papers are missing (see Section 4 below for specifics and BibTeX entries).
- Prose: Major sections (Introduction, Literature, Results, Discussion/Conclusion) are written in paragraph form, not bullets — good.
- Section depth: Most major sections have multiple substantive paragraphs. A few places (e.g., the end of Section 1, opening of some robustness subsections) are compact; but overall each major section contains 3+ substantive paragraphs. Acceptable.
- Figures: Figures are included and appear to show data (binned age means, density histogram, heterogeneity plots). Ensure every plotted axis has tick labels and units and that embedded PDF/PNG resolution is high. Current figure captions explain content but check the figures in the compiled PDF for legibility at journal page size.
- Tables: The manuscript references tables (summary, main RD table, balance, placebo, heterogeneity) and includes inputs for table files. I could not see the compiled numbers here, but the text reports point estimates with SEs and CIs (e.g., main RD estimate 0.027, SE = 0.002, 95% CI: 0.023–0.030). Ensure all table files are filled (no placeholders) and each regression table reports N and degrees of freedom where applicable.

2. STATISTICAL METHODOLOGY (CRITICAL)
A paper cannot pass without solid inference. The authors have made a serious effort; they meet many checklist items, but some key elements require additional work or clearer reporting.

a) Standard errors: PASS — Main coefficients are reported with standard errors (e.g., SE = 0.002 for the 0.027 Medicaid effect). But ensure every coefficient in every table has SEs or CIs in parentheses (including heterogeneity, placebo, covariate balance tables). Also report exactly how SEs are computed in each table (rdrobust bias‑corrected SE? heteroskedasticity‑robust? cluster?).
- Recommendation: In every regression table include (1) point estimate, (2) bias‑corrected SE (if using Calonico et al. correction) in parentheses, (3) 95% CI in square brackets or a second line, and (4) N for that regression.

b) Significance testing: PASS — p‑values reported, local randomization permutation p‑value reported. Good.

c) Confidence Intervals: PASS — the main results present 95% CIs (abstract, Section 1, Section 7). Ensure every main and robustness estimate includes 95% CIs in tables/figures.

d) Sample sizes: PARTIAL — The paper reports the overall sample size (1,639,017 births in main sample, Section 5.1 and Figure captions). But regression tables must report the N used in each RD (bandwidth varies). For example, when reporting the rdrobust estimates using the MSE‑optimal bandwidth, state the exact number of observations used within that bandwidth. Also for the local randomization tests (25 vs 26) report Ns for each side (n25, n26). Action: add N to each table.

e) RD with discrete running variable and “sharpness” of treatment:
- The manuscript correctly recognizes that MAGER (mother age) in the public-use natality files is recorded in integer years, producing a discrete running variable (Sections 5.4 and 6.3). The paper implements three complementary approaches: Kolesár & Rothe variance estimator for discrete RD, local randomization inference (Cattaneo et al. 2015), and simple age 25 vs 26 comparison. Authors also note measurement error (some recordedAge=26 mothers were still eligible due to plan rules/end of month).
- This is the central methodological challenge. Two outstanding concerns render the current evidence incomplete:
  1) Measurement of treatment assignment is not clearly sharp in practice. The dependent coverage rule in employer plans often terminates at end of month or end of plan year; some parents’ plans may have varying practices. The binary D_i = 1[A>=26] used in the RD may not correspond to actual loss of dependent coverage at the time of delivery. If treatment is not actually sharp at the observed running variable (because of plan timing variation), the design is effectively fuzzy. The paper claims attenuation bias but does not estimate a fuzzy RD (i.e., first stage: effect of age>=26 on actual parental coverage at delivery or on private coverage availability). Fix: obtain or construct a first‑stage measure of parental coverage (or private payment) and implement fuzzy RD (local LATE) using the age>=26 indicator as instrument for being on a parental plan (or for private coverage at delivery).
  2) The discrete age measure (years only) introduces misalignment of actual birthdate relative to the 26th birthday. The methods (Kolesár & Rothe, local randomization) partly address inference, but they do not solve the treatment measurement problem. The public file limitation is acknowledged (Section 13, Limitations); stronger identification requires restricted data with exact maternal DOB and infant birth date (or state vital statistics office linkage) so one can construct age in days and the true running variable with resolution at the day level.
- Verdict on RD: CONDITIONALLY PASS for inference if the authors (a) present clear first‑stage evidence that age>=26 strongly predicts loss of parental coverage or loss of private dependent coverage (so that the RD instrument is meaningful) and (b) either obtain restricted data with exact birthdates or convincingly implement a fuzzy RD that quantifies attenuation due to the discrete measurement and plan rules. Without such evidence the causal interpretation is weakened.

f) RDD robustness checks required by top journals:
- Bandwidth sensitivity: PASS — Figure 7 shows stability across bandwidths (Section 9.3).
- McCrary manipulation test: PASS — Figure 2 and McCrary test implemented and reported (Section 9.1).
- Polynomial order and kernel sensitivity: the text says robustness to polynomial order and kernel; please show these results in tables (e.g., local linear vs local quadratic, triangular vs rectangular kernels), with CIs and Ns.
- Placebo ages: PASS — placebo tests at ages 24,25,27,28 are presented (Section 9.3), but some placebo estimates are significant (the paper notes nonlinear age patterns). Authors must show robustness to alternative functional forms (e.g., higher order polynomials are discouraged; instead show local linear with narrower bandwidths, or fit flexible splines and show no discontinuity at 26).
- Multiple hypothesis testing: Many outcomes and subgroup analyses are shown. Declare whether adjustments for multiple testing are applied or argue that tests are pre‑specified and exploratory. At minimum, flag which outcomes are primary (Medicaid payment, private payment, self‑pay) vs secondary (prenatal care, preterm, LBW).

If the statistical methodology fails: I do not judge it a fatal failure yet, but it would be unpublishable in a top journal until the treatment measurement/fuzziness/discrete running variable issues are resolved as above. State that clearly: Without a clearer first stage and/or access to exact birthdates (and a fuzzy RD if necessary), the paper’s causal claims remain suggestive rather than definitive.

3. IDENTIFICATION STRATEGY (credibility, assumptions, tests)
- Credibility: The intuition is strong: dependent‑coverage eligibility stops at age 26; delivering mothers near that cutoff should face different coverage options. The use of RD is appropriate in principle (Section 6.1).
- Key assumptions: The paper discusses continuity of potential outcomes (Section 6.1) and addresses manipulation (McCrary) and covariate balance (Section 9.2). However:
  - The sharp RD assumption (perfect compliance at cutoff) is not fully credible here because of: (i) integer‑year running variable; (ii) heterogeneity in plan termination timing (end of month vs birthday vs end of plan year); and (iii) the analytic outcome is source of payment at delivery (which can be changed during pregnancy due to Medicaid enrollment). These imply fuzziness and measurement error; the paper needs to formalize the estimating equation as fuzzy RD or IV and present first‑stage estimates.
  - The argument that women cannot manipulate date of birth is correct but the possibility of manipulation in conception timing is discussed but plausibly limited; still, given heterogeneity in family planning, include additional robustness: test for discontinuities in conception month distributions (if exact conception/gestational age available) or examine distributions of gestational age/EDD near threshold to show no dramatic shifts.
- Placebo tests and robustness: Authors run many. But a few additional checks are recommended:
  - Exploit cross‑state heterogeneity (states that expanded Medicaid vs not; states where dependent coverage enforcement or plan termination rules vary) — Section 2 and 9 mention states but do not exploit them. If Medicaid expansion status modifies the first stage (falling into Medicaid is easier in expansion states), show state‑by‑state or split sample RD.
  - Use sibling/family fixed effects? Not possible here. But consider comparing births to women whose parents’ insurance status is observable (if any family coverage indicators exist) or using external data (e.g., ACS or MEPS) to estimate what fraction of women at age 25 vs 26 have parents’ employer coverage to construct a plausible first stage.
  - Check timing within the year: if the public file includes month of birth (often it does not), use that to refine the running variable. If month is available, use it to reduce discreteness (compare age 25 months 11 vs age 26 month 1).
- Do conclusions follow? Broadly, yes: payment shifts from private to Medicaid at age 26 are consistent with predictions. But the policy implication that the true causal effect is X (and the fiscal transfer is $54m) requires stronger evidence on compliance and local LATE interpretation.

4. LITERATURE (missing references and why to add them)
The review cites many papers that are relevant. Still, I recommend adding the following methodological and substantive references, with BibTeX entries as requested. These are important: they cover discrete RD inference, fuzzy RD/bandwidth/bias correction, and recent DiD/staggered TWFE literature that reviewers at top journals expect authors to demonstrate awareness of.

- Goodman‑Bacon (2021) — important reference on TWFE/staggered DiD; even though this paper is RD, prior DD literature on dependent coverage used TWFE and reviewers will expect mention of recent critiques. It helps position why RD is preferred here.

- Callaway & Sant’Anna (2021) — for DiD with staggered adoption; mention as alternative methods and to show authors know the current literature on identification methods.

- Imbens & Kalyanaraman (2012) — classic bandwidth selector for RD (authors use Calonico et al. 2014 but Imbens & Kalyanaraman is often cited too).

- Cattaneo, Jansson & Ma (2019) — inference and treatment of discrete running variables; or Cattaneo & Titiunik (2019) book/paper referenced but a specific paper on discrete running variable alternatives would be helpful.

- Also suggest including papers that use exact birthdates or restricted vital statistics to identify policy discontinuities (if any exist in the literature) — but I do not have a single canonical citation beyond the ones already used.

Provide BibTeX entries below for Goodman‑Bacon, Callaway & Sant’Anna, Imbens & Kalyanaraman, and Cattaneo et al. (2019 on discrete?) — I include the standard entries that a referee would expect.

BibTeX suggestions

@article{GoodmanBacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-differences with variation in treatment timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {254--277}
}

@article{CallawaySantAnna2021,
  author = {Callaway, Brantly and Sant'Anna, Pedro H. C.},
  title = {Difference-in-differences with multiple time periods},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  pages = {200--230}
}

@article{ImbensKalyanaraman2012,
  author = {Imbens, Guido W. and Kalyanaraman, Karthik},
  title = {Optimal bandwidth choice for the regression discontinuity estimator},
  journal = {Review of Economic Studies},
  year = {2012},
  volume = {79},
  pages = {933--959}
}

@article{CattaneoJanssonMa2019,
  author = {Cattaneo, Matias D. and Jansson, Michael and Ma, Xinwei},
  title = {Simple local polynomial density estimators},
  journal = {Journal of the American Statistical Association},
  year = {2019},
  volume = {114},
  pages = {1441--1450}
}

Why each is relevant
- Goodman‑Bacon (2021) and Callaway & Sant’Anna (2021): Even though the paper’s identification strategy is RD, many readers will be familiar with DD studies of the dependent coverage mandate. Cite these to (a) acknowledge advances in DD inference, and (b) explain why RD is an improvement for the specific research question (local causal effect at the policy threshold).
- Imbens & Kalyanaraman (2012): Classic bandwidth selection reference; many reviewers expect to see a comparison across established selectors (IK, Calonico et al., MSE‑optimal).
- Cattaneo et al. (2019): Provides techniques for density estimation and inference with discrete running variables and supports your use of local randomization and alternative variance estimators.

5. WRITING QUALITY (CRITICAL)
Overall the paper is well‑written relative to many working papers. But top general interest journals require crisp narrative and careful econometric exposition for a broad audience. Specific notes:

a) Prose vs bullets: PASS — No major sections rely on bullets. Good.

b) Narrative flow: Generally good. The Introduction sets the policy puzzle, motivates the RD, and previewed results. But tighten the Introduction: (i) bring the main identification challenges and key robustness steps into the intro in 2–3 sentences so the reader knows you address the biggest threats; (ii) better highlight which results are primary vs supplemental (payment source is primary; health outcomes secondary).

c) Sentence quality: Mostly good, but there is repetition (e.g., discussion of Medicaid importance appears repeatedly in Sections 2 and 3). Trim repetitive paragraphs; place the most important insights up front (e.g., the RD point estimate and key heterogeneity) so busy readers get the punchline early.

d) Accessibility: The econometric parts are generally accessible, but the discrete running variable discussion should be made more intuitive for non‑specialists. A short box/paragraph explaining why integer age creates attenuation (simple numerical example) would help.

e) Figures/Tables: Ensure figures and tables are self‑contained. For each figure: add an explicit y‑axis label (percentage of births), indicate sample (mothers aged 22–30), and annotate the number of observations in the plotted bins. For tables: include N, bandwidth used, polynomial order, kernel, and exact SE type (robust, bias‑corrected).

Major writing problems to fix before resubmission:
- Clarify the exact estimand: Is the paper estimating a sharp RD treatment effect (intent-to‑treat at observed age) or a local LATE (if fuzzy)? If the latter, present and interpret IV estimates. State explicitly in Section 6 and the Abstract.
- Move the limitations (discrete age, public file restriction) from the end into a prominent place in the methods section, and clearly explain what analyses can and cannot be performed with the public file.

6. CONSTRUCTIVE SUGGESTIONS (to make the paper more impactful)
If the paper genuinely aims for top‑journal publication, I recommend the following additions and changes (some are essential; others are desirable):

Essential (must do)
1. Resolve the measurement/treatment compliance issue:
   - Obtain restricted natality data (via NCHS or state vital statistics) that contain exact maternal date of birth and infant date of birth, so you can construct age in days and the true running variable. With precise running variable you can run a standard continuous RD and show sharper discontinuities.
   - If restricted data cannot be obtained, implement a fuzzy RD: instrument actual parental coverage (if observed) or individual private coverage at delivery with the age>=26 indicator, present first‑stage F statistic, and report IV LATE. If parental coverage is not observed in the natality file, construct plausible bounds using administrative or survey data.
2. Provide and report first stage:
   - Show directly how age>=26 affects being on a parental plan (or private coverage prior to delivery), or at least how it affects private coverage prior to any Medicaid enrollment. Present the first stage in a table with N and SE.
3. Report per‑regression N and exact SE methodology:
   - For rdrobust, report number of observations within the chosen bandwidth, the MSE‑optimal bandwidth value, the kernel, the polynomial order, bias‑correction details, and whether SEs are robust. For local randomization tests, report the exact window used and Ns on each side.
4. Address plan timing heterogeneity:
   - Document (from secondary sources or sample checks) how often parental plans terminate at the birthday vs end of month vs end of plan year. If possible, exploit states or employers with different rules or perform sensitivity analyses that assume different fractions of mothers whose parental coverage terminates at month/year boundaries.
5. Clarify estimand and interpret fiscal back‑of‑envelope carefully:
   - If your causal estimate is a local effect (around age 26), carefully describe who is in the local population and whether scaling to national births for the $54M fiscal transfer is warranted. Provide uncertainty bounds around that fiscal estimate.

Highly desirable (would strengthen paper)
6. State heterogeneity by state Medicaid expansion status:
   - Splitting sample by Medicaid expansion states could show how arrays of alternatives (Medicaid availability) shape the first stage and second stage. Expect larger shifts to Medicaid in expansion states; if not, that’s informative.
7. Examine timing within pregnancy:
   - If gestational age and month of first prenatal visit are available, check whether women above 26 experience delays in enrolling in care (not just payer at delivery). This helps interpret the early prenatal care decrease (Section 7.2) and the null effects for preterm/LBW.
8. Explore dynamic outcomes (postpartum coverage, infant readmissions) if linkages exist or cite limitations and propose future administrative linkage plans.
9. Robustness to multiple testing: address or control for multiple hypotheses across subgroups/outcomes, or explicitly state outcomes that were pre‑registered.

7. OVERALL ASSESSMENT
- Key strengths:
  - Policy‑relevant question with large, near‑universal administrative dataset.
  - Thoughtful use of RD; multiple robustness checks (rdrobust, McCrary, local randomization, bandwidth sensitivity).
  - Clear heterogeneity tests that support the mechanism (stronger effect for unmarried and less‑educated women).
- Critical weaknesses:
  - Treatment measurement ambiguity: integer age in the public data and heterogeneity in plan termination timing create fuzziness that undermines the “sharp” RD interpretation. The paper recognizes this but stops short of providing a formal fuzzy RD/first‑stage or providing restricted exact‑date analysis.
  - Some robustness and reporting details are missing (per‑regression N, explicit first stage, exact SE procedures across tables).
  - Fiscal/calculation extrapolations (the $54M figure) rest on scaling the local RD effect to national births; this requires careful qualification and uncertainty bounds.
- Concrete suggestions (recap):
  - Obtain restricted data with exact dates or implement a fuzzy RD with a reported first stage and LATE estimate.
  - Report N per regression, SE details, CIs, and show robustness tables for kernel/polynomial choices.
  - Add state/subsample analyses (Medicaid expansion, plan termination rule heterogeneity).
  - Tighten the writeup to emphasize the identification threats and how they are addressed; be cautious when scaling the local effect to national fiscal estimates.

8. DECISION (required)
Given the methodological promise but the central unresolved measurement/first‑stage issue and the need for stronger robustness/reporting to satisfy top general interest referees, I recommend substantial revision.

DECISION: MAJOR REVISION

(If the authors provide a revised submission that: (i) obtains exact‑date restricted data and re‑runs the RD with daily age; or (ii) implements a fuzzy RD with a convincing first stage and LATE interpretation, and (iii) addresses the reporting and robustness items above — then the paper would likely move to a favorable outcome.)